Skip to main content
. 2026 Mar 31;18(7):1120. doi: 10.3390/cancers18071120
BiP heavy chain binding protein
CDK cyclin/cyclin-dependent kinases
COX-2 cyclooxygenase-2
DCFH-CA 2’,7’-dichlorofluorescin diacetate
DHA docosahexaenoic acid
DMSO dimethyl sulfoxide
EMT epithelial–mesenchymal transition
EPA eicosapentaenoic acid
ER endoplasmic reticulum
FBS fetal bovine serum
IL-6 interleukin-6
IC50 half-maximal inhibitory concentration
IRE1-α inositol-requiring protein 1
MAPK mitogen-activated protein kinase
MTT methylthiazolyldiphenyl-tetrazolium bromide
mTOR mammalian target of rapamycin
NF-κB nuclear factor kappaB
PA palmitic acid
PARP poly(ADP-ribose) polymerase
PBS phosphate buffer saline
PI propidium iodide
PI3K phosphoinositide 3-kinase
PUFA polyunsaturated fatty acid
ROS reactive oxygen species
TNF-α tumor necrosis factor alpha
UPR unfolded protein response
USC uterine serous carcinoma